Drug Information

Drug General Information
Drug ID
D0X4NF
Former ID
DIB006451
Drug Name
Radiosensitizer gene therapy
Synonyms
Radiosensitizer gene therapy (prostate cancer)
Indication Pancreatic cancer [ICD9: 140-199, 140-229, 157, 210-229; ICD10:C25] Phase 3 [550209]
Company
Advantagene
Target and Pathway
Target(s) Thymidine kinase Target Info Inhibitor [534746]
References
Ref 550209Clinical pipeline report, company report or official report of Advantagene.
Ref 534746Pronounced antitumor effects and tumor radiosensitization of double suicide gene therapy. Clin Cancer Res. 1997 Nov;3(11):2081-8.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.